amifampridine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mainero, C | 1 |
| Inghilleri, M | 1 |
| Pantano, P | 1 |
| Conte, A | 1 |
| Lenzi, D | 1 |
| Frasca, V | 1 |
| Bozzao, L | 1 |
| Pozzilli, C | 1 |
1 trial available for amifampridine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine.
Topics: 4-Aminopyridine; Adult; Amifampridine; Axons; Cross-Over Studies; Double-Blind Method; Electromyogra | 2004 |